GlassScriptPhysician profile
Ashley Scott
NPI 1669049078
$2,921.03
in general payments reported to CMS, 2019-2025
23 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $264 · 2023: $477 · 2024: $687 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,448.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,575.17 | 2021-2025 | Onyx Frontier, Symplicity G3 |
| Kowa Pharmaceuticals America, INC. | $188.04 | 2025 | Zoryve |
| Phathom Pharmaceuticals, INC. | $170.82 | 2025 | Voquezna |
| Abbvie INC. | $149.26 | 2025 | |
| Xeris Pharmaceuticals, INC. | $99.23 | 2025 | Gvoke Hypopen |
| Pfizer INC. | $94.33 | 2023-2025 | |
| Cardiva Medical, INC. | $84.91 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Otsuka America Pharmaceutical, INC. | $68.59 | 2025 | Rexulti |
| Neurocrine Biosciences, INC. | $62.16 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $51.86 | 2025 | Airsupra, Farxiga |
| Exact Sciences Corporation | $51.58 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $48.52 | 2025 | Veozah |
| Almatica Pharma LLC | $39.32 | 2025 | Loreev Xr |
| Eisai INC. | $32.20 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $30.13 | 2025 | Austedo Xr |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $29.97 | 2025 | Wegovy |
| Shockwave Medical, INC | $28.56 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $24.36 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.50 | 2025 | |
| Dexcom, INC. | $18.71 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.81 | 2025 | Jardiance |
| Axsome Therapeutics, INC. | $17.34 | 2025 | Auvelity |
| Inogen, INC. | $16.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.